LeFonti AWARDS® Recognize Ortho Clinical Diagnostics with Global Award for Excellence in Innovation and Leadership

RARITAN, N.J., March 27, 2018 /PRNewswire/ -- Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that it has been recognized with a global LeFonti AWARD® for Excellence in Innovation in the diagnostics sector.  The award was presented at the 8^th Annual Le Fonti Innovation Awards celebration in Hong Kong on March 23, 2018. LeFonti AWARDS is one of the world's leading ranking systems, hosting award ceremonies in Excellence in Innovation & Leadership in key industries every year.  The selection committee is made up of the LeFonti scientific committee, along with a team of dedicated legal, economic and financial journalists in more than 120 countries worldwide. 

"Ortho has a long legacy of leadership in diagnostics," said Robert Yates, Ortho's chief operating officer.  "Our recent product launches, including numerous assays for clinical labs and the ORTHO VISION® Platform of immunohematology analyzers, underscore that commitment.

Over the last two years, Ortho has been broadly recognized for customer service, innovation, quality, safety, sustainability and brand renovation with several awards. 

• The Ortho Care™ service and support program has been the highest-ranked original equipment manufacturer by ServiceTrak™ for overall service performance in the chemistry and immunoassay market segments for two years running (2016-17).
• The Edison Award™ for Global Product Innovation, 2017 recognized the ORTHO VISION^® Analyzer, a fully automated immunohematology system that tests blood for compatibility with patients receiving blood transfusion.
• The ORTHO VISION Analyzer also received two Global Business Excellence Awards.
• Most recently, Ortho was recognized as one of The Economic Times Best Asian Healthcare Brands for 2017.

About the Award
LE FONTI® SRL is a research institute and a global independent publishing house headquartered in Milan with more than 10 years of experience in the publishing field, with major shareholders from Europe and Asia. LeFonti® is one of the fastest growing magazines worldwide concerning Excellence in Innovation & Leadership. It is a quarterly magazine published by LE FONTI ®. It is also the first of its kind, according to Alexa - Amazon, for international ranking and for its related number of readers. 

About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.

PR-03712

SOURCE Ortho Clinical Diagnostics

Related Links

http://www.orthoclinicaldiagnostics.com